home.social

#cellbiology — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #cellbiology, aggregated by home.social.

  1. SD-208, an experimental anti-fibrotic compound, significantly reduces the cellular release of extracellular vesicles by redirecting them for internal degradation.
    #CellBiology #Pharmacology #MolecularMedicine #sflorg
    sflorg.com/2026/09/cbio0930260

  2. SD-208, an experimental anti-fibrotic compound, significantly reduces the cellular release of extracellular vesicles by redirecting them for internal degradation.
    #CellBiology #Pharmacology #MolecularMedicine #sflorg
    sflorg.com/2026/09/cbio0930260

  3. SD-208, an experimental anti-fibrotic compound, significantly reduces the cellular release of extracellular vesicles by redirecting them for internal degradation.
    #CellBiology #Pharmacology #MolecularMedicine #sflorg
    sflorg.com/2026/09/cbio0930260

  4. SD-208, an experimental anti-fibrotic compound, significantly reduces the cellular release of extracellular vesicles by redirecting them for internal degradation.
    #CellBiology #Pharmacology #MolecularMedicine #sflorg
    sflorg.com/2026/09/cbio0930260

  5. Lung cancer cells can develop resistance to KRAS-inhibiting drugs either by amplifying the KRAS gene to reactivate its signaling or by transforming their cellular identity from adenocarcinoma to squamous cell carcinoma.
    #Oncology #MolecularGenetics #MolecularBiology #CellBiology #sflorg
    sflorg.com/2026/09/ongy0930260

  6. Lung cancer cells can develop resistance to KRAS-inhibiting drugs either by amplifying the KRAS gene to reactivate its signaling or by transforming their cellular identity from adenocarcinoma to squamous cell carcinoma.
    #Oncology #MolecularGenetics #MolecularBiology #CellBiology #sflorg
    sflorg.com/2026/09/ongy0930260

  7. Lung cancer cells can develop resistance to KRAS-inhibiting drugs either by amplifying the KRAS gene to reactivate its signaling or by transforming their cellular identity from adenocarcinoma to squamous cell carcinoma.
    #Oncology #MolecularGenetics #MolecularBiology #CellBiology #sflorg
    sflorg.com/2026/09/ongy0930260

  8. Lung cancer cells can develop resistance to KRAS-inhibiting drugs either by amplifying the KRAS gene to reactivate its signaling or by transforming their cellular identity from adenocarcinoma to squamous cell carcinoma.
    #Oncology #MolecularGenetics #MolecularBiology #CellBiology #sflorg
    sflorg.com/2026/09/ongy0930260

  9. Lung cancer cells can develop resistance to KRAS-inhibiting drugs either by amplifying the KRAS gene to reactivate its signaling or by transforming their cellular identity from adenocarcinoma to squamous cell carcinoma.
    #Oncology #MolecularGenetics #MolecularBiology #CellBiology #sflorg
    sflorg.com/2026/09/ongy0930260